tiprankstipranks
Trending News
More News >
Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
US Market

Eton Pharmaceuticals (ETON) Income Statement

Compare
515 Followers

Eton Pharmaceuticals Income Statement

Last quarter (Q3 2025), Eton Pharmaceuticals's total revenue was $22.46M, an increase of 117.54% from the same quarter last year. In Q3, Eton Pharmaceuticals's net income was $-1.93M. See Eton Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 39.01M$ 31.64M$ 21.25M$ 21.83M$ 39.00K
Gross Profit
$ 23.41M$ 21.06M$ 14.32M$ 19.21M$ -247.00K
Operating Expenses
$ 26.01M$ 22.25M$ 22.58M$ 20.70M$ 26.86M
Depreciation and Amortization
$ 1.15M$ 901.00K$ 1.77M$ 462.00K$ 651.00K
EBITDA
$ -1.45M$ -291.00K$ -6.49M$ -1.03M$ -26.46M
Operating Income
$ -2.60M$ -1.19M$ -8.26M$ -1.50M$ -27.11M
Other Income/Expenses
$ -1.21M$ 503.00K$ -761.00K$ -460.00K$ -859.00K
Pretax Income
$ -3.81M$ -689.00K$ -9.02M$ -1.96M$ -27.97M
Net Income
$ -3.82M$ -936.00K$ -9.02M$ -1.96M$ -27.97M
Per Share Metrics
Basic EPS
$ -0.15$ -0.04$ -0.36$ -0.08$ -1.33
Diluted EPS
$ -0.15$ -0.04$ -0.36$ -0.08$ -1.33
Weighted Average Shares Outstanding
25.89M 25.64M 25.15M 25.21M 21.01M
Weighted Average Shares Outstanding (Diluted)
25.89M 25.65M 25.15M 25.21M 21.01M
Currency in USD

Eton Pharmaceuticals Earnings and Revenue History